Serge Belanger
Stock Analyst at Needham
(4.38)
# 369
Out of 4,996 analysts
375
Total ratings
55.4%
Success rate
16.47%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Serge Belanger
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| KALV KalVista Pharmaceuticals | Reiterates: Buy | $28 | $12.40 | +125.81% | 21 | Sep 12, 2025 | |
| CYTK Cytokinetics | Reiterates: Buy | $72 | $50.40 | +42.86% | 24 | Sep 2, 2025 | |
| OCS Oculis Holding AG | Initiates: Buy | $36 | $17.68 | +103.68% | 1 | Aug 27, 2025 | |
| OMER Omeros | Reiterates: Hold | n/a | $4.46 | - | 8 | Aug 15, 2025 | |
| AMPH Amphastar Pharmaceuticals | Upgrades: Buy | $36 | $26.84 | +34.13% | 6 | Aug 12, 2025 | |
| LQDA Liquidia | Maintains: Buy | $32 → $36 | $21.80 | +65.14% | 33 | Aug 12, 2025 | |
| HRTX Heron Therapeutics | Maintains: Buy | $4 → $3 | $1.21 | +147.93% | 23 | Aug 8, 2025 | |
| TRVI Trevi Therapeutics | Maintains: Buy | $24 → $22 | $8.77 | +150.86% | 22 | Aug 8, 2025 | |
| ARQT Arcutis Biotherapeutics | Maintains: Buy | $20 → $22 | $17.57 | +25.21% | 22 | Aug 7, 2025 | |
| VRDN Viridian Therapeutics | Maintains: Buy | $36 → $34 | $20.18 | +68.48% | 18 | Aug 6, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | $22 | $5.99 | +267.59% | 16 | Aug 6, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $14 → $15 | $12.53 | +19.71% | 4 | Aug 5, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $17 | $7.63 | +122.80% | 16 | Aug 4, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | $45 | $4.04 | +1,013.86% | 16 | Jul 17, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $15 → $20 | $11.30 | +76.99% | 18 | Jun 24, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $40 | $28.50 | +40.35% | 9 | Jun 12, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Hold | n/a | $4.18 | - | 19 | May 14, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $66 | $61.99 | +6.47% | 13 | May 13, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $60 → $55 | $37.98 | +44.81% | 12 | May 13, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $32 → $30 | $25.24 | +18.86% | 28 | May 9, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $5 → $4 | $2.65 | +50.94% | 20 | May 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $46 | $34.41 | +33.68% | 25 | Apr 9, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | n/a | $2.74 | - | 1 | Mar 31, 2022 |
KalVista Pharmaceuticals
Sep 12, 2025
Reiterates: Buy
Price Target: $28
Current: $12.40
Upside: +125.81%
Cytokinetics
Sep 2, 2025
Reiterates: Buy
Price Target: $72
Current: $50.40
Upside: +42.86%
Oculis Holding AG
Aug 27, 2025
Initiates: Buy
Price Target: $36
Current: $17.68
Upside: +103.68%
Omeros
Aug 15, 2025
Reiterates: Hold
Price Target: n/a
Current: $4.46
Upside: -
Amphastar Pharmaceuticals
Aug 12, 2025
Upgrades: Buy
Price Target: $36
Current: $26.84
Upside: +34.13%
Liquidia
Aug 12, 2025
Maintains: Buy
Price Target: $32 → $36
Current: $21.80
Upside: +65.14%
Heron Therapeutics
Aug 8, 2025
Maintains: Buy
Price Target: $4 → $3
Current: $1.21
Upside: +147.93%
Trevi Therapeutics
Aug 8, 2025
Maintains: Buy
Price Target: $24 → $22
Current: $8.77
Upside: +150.86%
Arcutis Biotherapeutics
Aug 7, 2025
Maintains: Buy
Price Target: $20 → $22
Current: $17.57
Upside: +25.21%
Viridian Therapeutics
Aug 6, 2025
Maintains: Buy
Price Target: $36 → $34
Current: $20.18
Upside: +68.48%
Aug 6, 2025
Downgrades: Hold
Price Target: $22
Current: $5.99
Upside: +267.59%
Aug 5, 2025
Maintains: Buy
Price Target: $14 → $15
Current: $12.53
Upside: +19.71%
Aug 4, 2025
Maintains: Buy
Price Target: $17
Current: $7.63
Upside: +122.80%
Jul 17, 2025
Downgrades: Hold
Price Target: $45
Current: $4.04
Upside: +1,013.86%
Jun 24, 2025
Maintains: Buy
Price Target: $15 → $20
Current: $11.30
Upside: +76.99%
Jun 12, 2025
Reiterates: Buy
Price Target: $40
Current: $28.50
Upside: +40.35%
May 14, 2025
Reiterates: Hold
Price Target: n/a
Current: $4.18
Upside: -
May 13, 2025
Reiterates: Buy
Price Target: $66
Current: $61.99
Upside: +6.47%
May 13, 2025
Maintains: Buy
Price Target: $60 → $55
Current: $37.98
Upside: +44.81%
May 9, 2025
Maintains: Buy
Price Target: $32 → $30
Current: $25.24
Upside: +18.86%
May 7, 2025
Maintains: Buy
Price Target: $5 → $4
Current: $2.65
Upside: +50.94%
Apr 9, 2025
Reiterates: Buy
Price Target: $46
Current: $34.41
Upside: +33.68%
Mar 31, 2022
Downgrades: Hold
Price Target: n/a
Current: $2.74
Upside: -